Shandong Weigao Medical Polymer Statistics
Share Statistics
Shandong Weigao Medical Polymer has 282.65M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 282.65M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 383 |
| FTD / Avg. Volume | 13.3% |
Short Selling Information
The latest short interest is 381, so 0% of the outstanding
shares have been sold short.
| Short Interest | 381 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 2.42 and the forward
PE ratio is null.
Shandong Weigao Medical Polymer's PEG ratio is
0.53.
| PE Ratio | 2.42 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0 |
| PB Ratio | 0.21 |
| P/FCF Ratio | 2.34 |
| PEG Ratio | 0.53 |
Financial Ratio HistoryEnterprise Valuation
Shandong Weigao Medical Polymer has an Enterprise Value (EV) of 16.45B.
| EV / Sales | 1.26 |
| EV / EBITDA | 4.36 |
| EV / EBIT | 5.9 |
| EV / FCF | 7.68 |
Financial Position
The company has a current ratio of 3.2,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.2 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 1.96 |
| Interest Coverage | 9.56 |
Financial Efficiency
Return on Equity is 8.7% and Return on Invested Capital is 6.75%.
| Return on Equity | 8.7% |
| Return on Assets | 5.95% |
| Return on Invested Capital | 6.75% |
| Revenue Per Employee | $1,028,938.67 |
| Profits Per Employee | $162,486.67 |
| Employee Count | 12,719 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 2.57 |
Taxes
| Income Tax | 391.03M |
| Effective Tax Rate | 15.31% |
Stock Price Statistics
The stock price has increased by 14.12% in the
last 52 weeks. The beta is 0.5, so Shandong Weigao Medical Polymer's
price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | 14.12% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 54.67 |
| Average Volume (20 Days) | 2,880 |
Income Statement
In the last 12 months, Shandong Weigao Medical Polymer had revenue of 13.09B
and earned 2.07B
in profits. Earnings per share was 7.36.
| Revenue | 13.09B |
| Gross Profit | 6.58B |
| Operating Income | 2.39B |
| Net Income | 2.07B |
| EBITDA | 3.78B |
| EBIT | 2.8B |
| Earnings Per Share (EPS) | 7.36 |
Full Income StatementBalance Sheet
The company has 7.78B in cash and 4.19B in
debt, giving a net cash position of 3.59B.
| Cash & Cash Equivalents | 7.78B |
| Total Debt | 4.19B |
| Net Cash | 3.59B |
| Retained Earnings | 19.85B |
| Total Assets | 34.76B |
| Working Capital | 13.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 2.79B
and capital expenditures -647.43M, giving a free cash flow of 2.14B.
| Operating Cash Flow | 2.79B |
| Capital Expenditures | -647.43M |
| Free Cash Flow | 2.14B |
| FCF Per Share | 1.89 |
Full Cash Flow StatementMargins
Gross margin is 50.28%, with operating and profit margins of 18.23% and 15.79%.
| Gross Margin | 50.28% |
| Operating Margin | 18.23% |
| Pretax Margin | 19.51% |
| Profit Margin | 15.79% |
| EBITDA Margin | 28.85% |
| EBIT Margin | 18.23% |
| FCF Margin | 16.37% |
